Clinical Adoption Day 2020

Actions and Detail Panel

Sales Ended

Sales Have Ended

Registrations are closed
Thank you for registering! We look forward to welcoming you at the event. Feel free to email comms@ct.catapult.org.uk if you have any questions.

Event Information

Share this event

Date and Time

Location

Location

Online Event

Sales Have Ended

Registrations are closed
Thank you for registering! We look forward to welcoming you at the event. Feel free to email comms@ct.catapult.org.uk if you have any questions.
Event description
Implementing innovation in clinical trials and beyond to advance institutional readiness and routine adoption of ATMPs

About this Event

The clinical development of Advanced Therapy Medicinal Products (ATMPs) presents unique challenges. Whilst they may be transformative for patients, their optimal design, clinical delivery and long-term benefits are still to be determined. Innovative clinical trial design allows for trials to be adapted to emerging clinical data and manufacturing innovation resulting in potential improved speed and efficiency of trials, shortened time to market and ultimately accelerating patient access to treatments.

Also central to this work is the ability to assess and improve institutional readiness (IR) of hospitals and clinics to implement this innovation in clinical delivery of ATMPs as more of these new therapies enter clinical studies and reach market authorisation.

Such innovation requires close collaboration between developers, regulators, payers and clinical trial sites to ensure evidence requirements are met. The Cell and Gene Therapy Catapult, Association of British Pharmaceutical Industry (ABPI) and UK BioIndustry Association (BIA) jointly invite you to explore the interfaces in these collaborations and to specifically identify and discuss areas for improvements and key recommendations.

You can view the full agenda below.

You can view highlights from last year's event here.

This event is held in partnership with the Advanced Therapy Treatment Centre (ATTC) network, and London Advanced Therapies (LAT).

Please RSVP by registering above. We look forward to welcoming you to the meeting.

  • 13:00-13:05, Welcome and introduction
  • 13.05-13.15, Direction of travel for the ATTC network
  • 13.15-13.30, Institutional Readiness for ATMP Adoption
  • 13.30-13.45, Patient focus within the ATMP landscape
  • 13.45-14.00, Ramping up to a national ATMP training programme
  • 14.00-14.15, Update on the London Advanced Therapies programme
  • 14.15-14.35, Making the UK attractive to run advanced therapy trials
  • 14.35-14.45, Break
  • 14.45-15.30, Panel discussion: Identifying solutions to overcoming clinical operations challenges arising from innovative clinical trials design
  • 15.30-15.35, Break
  • 15.35-16.25, Presentation and Panel discussion: Identifying innovative solutions to overcoming reimbursement challenges arising from advanced therapy clinical trials
  • 16.25-16.30, Summary of outputs and close

Watch highlights from last year's event focussing on digital challenges in adoption of ATMPs by the NHS:

Date and Time

Location

Online Event

Save This Event

Event Saved